SBC Medical Group
SBC | NASDAQ
$5.28
-$0.41 (-7.21%)
At close: Oct 30, 2026, 3:59 PM ET
$5.27
-$0.01 (-0.19%)
Pre-market:
Nov 2, 2026, 4:10 AM ET
-7.21%
(1D)No price chart data available for 1D timeframe.
Rating
74
-3.0 ptsFundamentals Excellent
Market Sentiment Neutral
Moat Narrow
Sector Rank #32/885 (Top 4%)
Key Statistics
Market Data
Market Cap $543.03M
1D Range
5.23 5.66
52W Range
2.87 5.69
Valuation (TTM)
PE 11.23
PB 2.06
EV/EBITDA 5.32
Valuation (NTM)
Forward PE 10.52
Forward PEG 28.49
Price Target $12.00
Cash Flow
FCF Yield 13.8%
SBC Adj. FCF Yield 13.8%
SBC Impact N/A
Margins
Gross Margin 71.3%
Operating Margin 37.3%
FCF Margin 42.8%
Growth (CAGR)
Revenue 3Y | 5Y 27.8% |
N/A
Dil EPS 3Y | 5Y 97.1% |
N/A
FCF 3Y | 5Y 12.6% |
N/A
Returns
ROA 12.1%
ROE 19.3%
ROIC 12.6%
Financial Health
Net Cash
$146.86M
Current Ratio 3.31
Interest Coverage 187.88
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
SBC Medical Group Holdings Incorporated provides comprehensive operational support to aesthetic and cosmetic clinics across a global footprint, including Japan, Vietnam, the United States, and other i...
Sector Industrials
Industry Consulting Services
Employees 863
IPO Date Sep 26, 2022
Website sbc-holdings.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$12.00
Upside
+127.27%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove SBC